Drug Profile
Research programme: cancer vaccines - Fukushima Medical University/OncoTherapy
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Fukushima Medical University; OncoTherapy Science
- Class Cancer vaccines; Dendritic cell vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Cancer in Japan (Parenteral)
- 05 Aug 2013 Early research in Cancer in Japan (Parenteral)